Curative Pharmaceuticals Private Limited
About Curative Pharmaceuticals Private Limited
Data last updated:
Curative Pharmaceuticals Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the retail trade segment of the home appliances and consumer durables sector. It was incorporated on 15 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52100WB2020PTC238060. Its GSTIN is 19AAICC8167B1ZJ (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Biresh Kumar and Hemant Prasad Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shaktigarh Road No. 3, Siliguri, West Bengal, India – 734005.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.53 Lakh, a growth of 120% compared to the previous year. For the same year it recorded a net profit of ₹87,745 (net margin 3.9%) and EBITDA of ₹94,017 (EBITDA margin 4.2%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShaktigarh Road No. 3, Siliguri, West Bengal, India – 734005
- IndustryHome Appliances, Retailers, Non Specialized Stores
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Curative Pharmaceuticals Private Limited
The main business activity of Curative Pharmaceuticals is trade. In detail, this covers retail trading and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Curative Pharmaceuticals Private Limited FY 2025 filings available
Curative Pharmaceuticals Private Limited reported revenue of ₹22.53 Lakh (up 120% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Curative Pharmaceuticals Private Limited
Revenue rose 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Curative Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹94,017 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹87,745 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Curative Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curative Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biresh Kumar | Director | 15 Jul 2020 | 6 Years 3 Months | Current |
| Hemant Prasad Gupta | Director | 15 Jul 2020 | 6 Years 3 Months | Current |
| Ranjan Kumar Thakur | Director | 15 Jul 2020 | 6 Years 3 Months | Current |
Peer Comparison of Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inocta Pharmaceuticals Private Limited | ₹22.7 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Patna, Bihar, India |
| Emphaatic Pharmaceuticals Private Limited | ₹22.69 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Navi Mumbai, Maharashtra, India |
| Hummock Pharmaceuticals Private Limited | ₹22.64 Lakh (FY 2020) | •••• | •••• | •••• | Bhopal, Madhya Pradesh, India | |
| Navante Pharmaceuticals Private Limited | ₹22.6 Lakh (FY 2025) | •••• | •••• | •••• | Vijayawada, Andhra Pradesh, India | |
| Midsun Pharmaceuticals Private Limited | ₹22.59 Lakh (FY 2025) | •••• | •••• | 62.0% | •••• | Yeshwanthpur, Karnataka, India |
| Curative Pharmaceuticals Private Limited this company | ₹22.53 Lakh (FY 2025) | •••• | •••• | 120.0% | •••• | Siliguri, West Bengal, India |
| Anvi Pharmaceuticals Private Limited | ₹22.51 Lakh (FY 2023) | •••• | •••• | -94.0% | •••• | Mumbai, Maharashtra, India |
| Medvelis Pharmaceuticals Private Limited | ₹22.51 Lakh (FY 2024) | •••• | •••• | 107.0% | •••• | Aurangabad, Maharashtra, India |
| Faithmed Pharmaceuticals Private Limited | ₹22.47 Lakh (FY 2024) | •••• | •••• | 95.0% | •••• | Nagpur, Maharashtra, India |
| Meshu Pharmaceuticals Private Limited | ₹22.47 Lakh (FY 2025) | •••• | •••• | 72.0% | •••• | Chandigarh, India |
| Medinet Pharmaceuticals Private Limited | ₹22.44 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Curative Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Curative Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Biresh Kumar was appointed as Director on 15 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Curative Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curative Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curative Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAICC8167B1ZJ | West Bengal | Active | 27 Oct 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curative Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curative Pharmaceuticals Private Limited
Curative Pharmaceuticals is an active private limited company based in Siliguri, West Bengal, India. The company works in retailers, within the home appliances industry. It was incorporated on 15 July 2020 (6+ years old) and is registered under CIN U52100WB2020PTC238060.
Curative Pharmaceuticals reported revenue of ₹22.53 Lakh for FY 2025 (up 120% YoY).
Curative Pharmaceuticals has 3 current directors:
- Biresh Kumar - Director
- Hemant Prasad Gupta - Director
- Ranjan Kumar Thakur - Director
Curative Pharmaceuticals reported a net profit of ₹87,745 (net margin 3.9%) and EBITDA of ₹94,017 (EBITDA margin 4.2%) for FY 2025, as per its filed financial statements.
The GSTIN of Curative Pharmaceuticals is 19AAICC8167B1ZJ, registered in West Bengal.
The CIN (Corporate Identification Number) of Curative Pharmaceuticals is U52100WB2020PTC238060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curative Pharmaceuticals was incorporated on 15 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Curative Pharmaceuticals by revenue are Inocta Pharmaceuticals Private Limited, Emphaatic Pharmaceuticals Private Limited, Hummock Pharmaceuticals Private Limited, Navante Pharmaceuticals Private Limited, Midsun Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Biresh Kumar was appointed as Director on 15 Jul 2020. Hemant Prasad Gupta was appointed as Director on 15 Jul 2020. Ranjan Kumar Thakur was appointed as Director on 15 Jul 2020.
The registered office of Curative Pharmaceuticals is at Shaktigarh Road No. 3, Siliguri, West Bengal, India – 734005.
Curative Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh.